NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/18/2022
Back to search
Official data from USPTO
SYBODY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SYBODY
ST13
US500000079279166Class
1, 5, 42
Filing
79279166
Registration
6571257
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
12/18/2022
Trademark type
Word
Nice classes
1, 5, 42
Filing date
12/20/2019
Registration date
11/30/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/30/2021
Last transaction
11/30/2021
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
CH
Examiner
LAM, HAI-LY
Law office
N10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Linkster Therapeutics AG
R. D. (pessoa física)
I. Z. (pessoa física)
P. E. (pessoa física)
Representatives
Julie Reitz Honigman LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Diagnostic preparations for scientific and research purposes; diagnostic reagents for scientific and research purposes; diagnostic preparations for scientific usemoleculesantibodiesnanobodiespeptidestarget molecules; chemical and biochemical substances for in vitro and in vivo scientific use; chemical materialschemical agents for chelating and sequesteringrheology modifiers for use in the field of coating materials and chemical preparationschemical preparations for scientific purposesindustrial chemicals and natural elementsdiamond molecules for use in pharmaceuticals
Class 5
Pharmaceutical preparationsnovel therapeutic antibodies; medical and veterinary preparations in the nature of vaccines; bacterial preparations for medical and veterinary use; medical preparations for the treatment of gout; veterinary preparations for treatment of intestinal bacteria; hygienic products for medical usedisinfectants for medical hygienic purposes; all of the aforementioned exclude vitamin supplements
Class 42
Scientific research services for identification and quantification of moleculesin particular polypeptidesfrom a series of molecules; scientific research services using a series of bar codes for identifying molecules selected by mass spectrometry; scientific analyses in the field of molecular biology; consultancy in the field of technological research in the area of diagnostic preparations; scientific advice relating to research and development in the field of therapeutic procedures; consulting services in the field of pharmaceutical research; consulting services for gene therapy research; provision of scientific information and data relating to medical and veterinary product research and development; biochemical and biotechnological research and development; researchtesting and computer-aided scientific analysis in the field of pharmaceuticals and biochemicals; scientific research in the field of proteinsantibodiesmicroorganisms and cells; computer software development
Publications
History of USPTO decisions and trademark events.
36 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/05/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/10/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/19/2022
FIMP
FINAL DISPOSITION PROCESSED
05/18/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/28/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
11/30/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/14/2021
PUBO
PUBLISHED FOR OPPOSITION
09/14/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/26/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/25/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/25/2021
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
08/07/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/06/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/05/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/05/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
08/05/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/21/2021
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
07/21/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/09/2021
GNFR
FINAL REFUSAL E-MAILED
02/09/2021
CNFR
FINAL REFUSAL WRITTEN
02/09/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/20/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/20/2021
ALIE
ASSIGNED TO LIE
01/07/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/29/2020
CHLD
CHANGE OF OWNER RECEIVED FROM IB
08/13/2020
RFNT
REFUSAL PROCESSED BY IB
04/24/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/08/2020
RFRR
REFUSAL PROCESSED BY MPU
04/08/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/21/2020
CNRT
NON-FINAL ACTION WRITTEN
03/20/2020
DOCK
ASSIGNED TO EXAMINER
03/18/2020
MAFR
APPLICATION FILING RECEIPT MAILED
02/28/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/24/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/20/2020
Continuous trademark protection
Get notified about every new filing that threatens SYBODY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.